Graft rejection in keratoplasty- what are the benefits of systemic immune modulation
Acta Ophthalmologica, 08/09/2012
Gruenert A – Systemic immunosuppression prolongs corneal allograft survival and reduces the risk of graft rejections. While the use of systemic immunosuppressive drugs is beneficial in the perioperative stage, the long–term–use is restricted to high–risk settings.



